Vertex Pharmaceuticals (VRTX) Cash from Operations (2009 - 2026)
Vertex Pharmaceuticals' quarterly Cash from Operations came in at 1428100000.0 in Q1 2026, up 74.39% year-on-year from 818900000.0 in Q1 2025, and up 186.77% quarter-over-quarter from 498000000.0 in Q4 2025.
Vertex Pharmaceuticals has reported Cash from Operations for 18 years, with the latest figure at 1428100000.0 in Q1 2026.
- For the quarter ending Q1 2026, Cash from Operations rose 74.39% year-over-year to 1428100000.0; the trailing twelve-month figure through Mar 2026 stood at 4240600000.0 (up 532.58% YoY), and the FY2025 full-year result was 3631400000.0, up 837.19% from the prior year.
- Cash from Operations for Q1 2026 stood at 1428100000.0, up from 498000000.0 in the prior quarter.
- The five-year high for Cash from Operations was 1428100000.0 in Q1 2026, with the low at 3753600000.0 in Q2 2024.
- Average Cash from Operations over 5 years is 719652941.18, with a median of 1073100000.0 recorded in 2025.
- Year-over-year, Cash from Operations surged 670.76% in 2022 and sank 430.89% in 2024.
- Tracing VRTX's Cash from Operations over 5 years: stood at 1078400000.0 in 2022, then sank by 78.25% to 234600000.0 in 2023, then surged by 149.19% to 584600000.0 in 2024, then slipped by 14.81% to 498000000.0 in 2025, then jumped by 186.77% to 1428100000.0 in 2026.
- The last three Cash from Operations figures came in at 1428100000.0 (Q1 2026), 498000000.0 (Q4 2025), and 1241400000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -1.67 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -12.20 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -2.49 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.43 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 1.08 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 70.50 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | -354.17 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.43 Bn |
| Mar 31, 2026 | 1.43 Bn |
| Dec 31, 2025 | 498.00 Mn |
| Dec 31, 2025 | 498.00 Mn |
| Sep 30, 2025 | 1.24 Bn |
| Sep 30, 2025 | 1.24 Bn |
| Jun 30, 2025 | 1.07 Bn |
| Jun 30, 2025 | 1.07 Bn |
| Mar 31, 2025 | 818.90 Mn |
| Mar 31, 2025 | 818.90 Mn |
| Dec 31, 2024 | 584.60 Mn |
| Dec 31, 2024 | 584.60 Mn |
| Sep 30, 2024 | 1.37 Bn |
| Sep 30, 2024 | 1.37 Bn |
| Jun 30, 2024 | -3.75 Bn |
| Jun 30, 2024 | -3.75 Bn |
| Mar 31, 2024 | 1.31 Bn |
| Mar 31, 2024 | 1.31 Bn |
| Dec 31, 2023 | 234.60 Mn |
| Dec 31, 2023 | 234.60 Mn |
| Sep 30, 2023 | 1.27 Bn |
| Sep 30, 2023 | 1.27 Bn |
| Jun 30, 2023 | 1.13 Bn |
| Jun 30, 2023 | 1.13 Bn |
| Mar 31, 2023 | 899.90 Mn |
| Mar 31, 2023 | 899.90 Mn |
| Dec 31, 2022 | 1.08 Bn |
| Dec 31, 2022 | 1.08 Bn |
| Sep 30, 2022 | 955.50 Mn |
| Sep 30, 2022 | 955.50 Mn |
| Jun 30, 2022 | 1.14 Bn |
| Jun 30, 2022 | 1.14 Bn |
| Mar 31, 2022 | 956.20 Mn |
| Mar 31, 2022 | 956.20 Mn |
| Dec 31, 2021 | 995.00 Mn |
| Dec 31, 2021 | 995.00 Mn |
| Sep 30, 2021 | 927.20 Mn |
| Sep 30, 2021 | 927.20 Mn |
| Jun 30, 2021 | -199.70 Mn |
| Jun 30, 2021 | -199.70 Mn |
| Mar 31, 2021 | 921.00 Mn |
| Mar 31, 2021 | 921.00 Mn |
| Dec 31, 2020 | 491.53 Mn |
| Dec 31, 2020 | 491.53 Mn |
| Sep 30, 2020 | 907.75 Mn |
| Sep 30, 2020 | 907.75 Mn |
| Jun 30, 2020 | 1.04 Bn |
| Jun 30, 2020 | 1.04 Bn |
| Mar 31, 2020 | 815.70 Mn |
| Mar 31, 2020 | 815.70 Mn |
| Dec 31, 2019 | 445.98 Mn |
| Dec 31, 2019 | 445.98 Mn |
| Sep 30, 2019 | 334.79 Mn |
| Sep 30, 2019 | 334.79 Mn |
| Jun 30, 2019 | 463.75 Mn |
| Jun 30, 2019 | 463.75 Mn |
| Mar 31, 2019 | 324.78 Mn |
| Mar 31, 2019 | 324.78 Mn |
| Dec 31, 2018 | 314.58 Mn |
| Dec 31, 2018 | 314.58 Mn |
| Sep 30, 2018 | 381.35 Mn |
| Sep 30, 2018 | 381.35 Mn |
| Jun 30, 2018 | 321.70 Mn |
| Jun 30, 2018 | 321.70 Mn |
| Mar 31, 2018 | 252.66 Mn |
| Mar 31, 2018 | 252.66 Mn |
| Dec 31, 2017 | 227.51 Mn |
| Dec 31, 2017 | 227.51 Mn |
| Sep 30, 2017 | 170.09 Mn |
| Sep 30, 2017 | 170.09 Mn |
| Jun 30, 2017 | 181.65 Mn |
| Jun 30, 2017 | 181.65 Mn |
| Mar 31, 2017 | 265.69 Mn |
| Mar 31, 2017 | 265.69 Mn |
| Dec 31, 2016 | 144.72 Mn |
| Dec 31, 2016 | 144.72 Mn |
| Sep 30, 2016 | 65.66 Mn |
| Sep 30, 2016 | 65.66 Mn |
| Jun 30, 2016 | 40.86 Mn |
| Jun 30, 2016 | 40.86 Mn |
| Mar 31, 2016 | -15.14 Mn |
| Mar 31, 2016 | -15.14 Mn |
| Dec 31, 2015 | 29.14 Mn |
| Dec 31, 2015 | 29.14 Mn |
| Sep 30, 2015 | -62.07 Mn |
| Sep 30, 2015 | -62.07 Mn |
| Jun 30, 2015 | -110.27 Mn |
| Jun 30, 2015 | -110.27 Mn |
| Mar 31, 2015 | -222.24 Mn |
| Mar 31, 2015 | -222.24 Mn |
| Dec 31, 2014 | -181.78 Mn |
| Dec 31, 2014 | -181.78 Mn |
| Sep 30, 2014 | -87.65 Mn |
| Sep 30, 2014 | -87.65 Mn |
| Jun 30, 2014 | -127.92 Mn |
| Jun 30, 2014 | -127.92 Mn |
| Mar 31, 2014 | -175.76 Mn |
| Mar 31, 2014 | -175.76 Mn |
| Dec 31, 2013 | 19.76 Mn |
| Dec 31, 2013 | 19.76 Mn |
| Sep 30, 2013 | -13.72 Mn |
| Sep 30, 2013 | -13.72 Mn |
| Jun 30, 2013 | -927,000.00 |
| Jun 30, 2013 | -927,000.00 |
| Mar 31, 2013 | -65.78 Mn |
| Mar 31, 2013 | -65.78 Mn |
| Dec 31, 2012 | 40.56 Mn |
| Dec 31, 2012 | 40.56 Mn |
| Sep 30, 2012 | 105.96 Mn |
| Sep 30, 2012 | 105.96 Mn |
| Jun 30, 2012 | 118.41 Mn |
| Jun 30, 2012 | 118.41 Mn |
| Mar 31, 2012 | 2.92 Mn |
| Mar 31, 2012 | 2.92 Mn |
| Dec 31, 2011 | 503.66 Mn |
| Dec 31, 2011 | 503.66 Mn |
| Sep 30, 2011 | 42.90 Mn |
| Sep 30, 2011 | 42.90 Mn |
| Mar 31, 2011 | -186.63 Mn |
| Mar 31, 2011 | -186.63 Mn |
| Dec 31, 2010 | -166.10 Mn |
| Dec 31, 2010 | -166.10 Mn |
| Sep 30, 2010 | -163.99 Mn |
| Sep 30, 2010 | -163.99 Mn |
| Jun 30, 2010 | -108.89 Mn |
| Jun 30, 2010 | -108.89 Mn |
| Mar 31, 2010 | -196.46 Mn |
| Mar 31, 2010 | -196.46 Mn |
| Dec 31, 2009 | -102.33 Mn |
| Dec 31, 2009 | -102.33 Mn |
| Sep 30, 2009 | -21.64 Mn |
| Sep 30, 2009 | -21.64 Mn |
| Jun 30, 2009 | -118.07 Mn |
| Jun 30, 2009 | -118.07 Mn |
| Mar 31, 2009 | -185.56 Mn |
| Mar 31, 2009 | -185.56 Mn |